On the monthly chart, the price is going bearish
and currently there are swings within the level conversion zone. We are
expecting the price to go upward if the trend line is being violated and the
price is stabilized above that line.
• Fortis Healthcare: sells its stake in Fortis Medicare International Limited to Fortis Global Healthcare. • Ajanta Pharma: gets US FDA nod for Migraine drug, Eletriptan hydro bromide tablet. CapitalStars
• Fortis Healthcare: sells its stake in Fortis Medicare International Limited to Fortis Global Healthcare.
ReplyDelete• Ajanta Pharma: gets US FDA nod for Migraine drug, Eletriptan hydro bromide tablet.
CapitalStars